Physician profile
Tara Mudd
NPI 1962789305
$242,601.69
in general payments reported to CMS, 2019-2025
15 companies · $54K in 2025
The $54K reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27K · 2022: $31K · 2023: $67K · 2024: $64K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $145K · Travel and Lodging: $26K · Food and Beverage: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $145,425.00 |
| Travel and Lodging | $25,531.04 |
| Food and Beverage | $13,786.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $229,433.66 | 2021-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Biosense Webster, INC. | $7,954.39 | 2021-2025 | Carto 3 |
| Boston Scientific Corporation | $2,262.19 | 2022-2024 | Watchman Access System |
| Edwards Lifesciences Corporation | $1,323.98 | 2023-2025 | Evoque |
| Irhythm Technologies, INC. | $965.64 | 2024 | Zio Monitor, Zio Xt Patch |
| Abbott Laboratories | $166.45 | 2023 | Navitor |
| Abbvie INC. | $156.27 | 2024-2025 | |
| Medtronic, INC. | $116.48 | 2024 | Micra |
| E.R. Squibb & Sons, L.L.C. | $107.82 | 2022 | |
| Janssen Pharmaceuticals, INC | $24.50 | 2022 | |
| Pfizer INC. | $24.18 | 2022 | |
| Sanofi-Aventis U.S. LLC | $19.22 | 2022 | |
| Eisai INC. | $16.28 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.12 | 2022 | |
| Getinge USA Sales, LLC | $14.51 | 2025 | Cardiohelp |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Mudd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.